to neuroblastoma cells (34) and to itself (15) .
Studies on the subunit composition of the adult form of N-CAM in chick (6) and mouse (12) have mapped the cell binding site and most of the sialic acid residues to proteolytic fragments localized on the outside of the cell. The extracellularly localized amino-terminal ends of the three components share identical amino acid sequences and have nearly identical patterns on peptide maps (6) . The 180-, 140-, and 120-kD chains differ only in the length of their carboxy-terminal ends which extend into the cytoplasm. The three protein chains are presumed to be identical in the adult and embryonic forms (12, 29) .
While some structural aspects and the membrane disposition of the three components have been investigated, their individual contributions to cell interactions during development of the nervous system have remained elusive. As a first step toward delineating their possible roles specific antibodies distinguishing the individual components would be valuable. One such antibody was found during the course of characterizing monoclonal antibodies against membrane fractions from neonatal mouse brain. The antibody was shown to react specifically with the 180-kD component of mouse N-CAM (N-CAM;go). Here, we report that N-CAM,80 is expressed during development at later stages than the other components and is localized differentially at contact sites between cultured neural tumor cells.
MATERIALS AND METHODS
Animals: C57BL/6J mice were used for membrane preparations, cell cultures, and immunohistological preparations. Their origin and maintenance have been described (37) . Mouse embryos were taken from timed pregnancies. Embryonic day 0 was taken as the day a vaginal plug was found. For immunization with membrane preparations 6-wk-old Fl hybrid animals from a cross between Sprague-Dawley and Lou Wistar parents were used.
Preparation of Crude Membrane Fraction: 100 neonatal mouse
brains were homogenized in 20 ml Tris buffer (25 mM Tris, 5 mM MgCI, 100 mM KCI, pH 7.4) containing 0.32 M sucrose plus soybean trypsin inhibitor and eggwhite trypsin inhibitor (10 ug/ml each) (Boehringer Mannheim Co., Mannheim. FRG). The homogenate was centrifuged in 10-ml aliquots through sucrose step gradients (12.5 ml each of 1.2, 0.8, and 0.32 M sucrose in Tris buffer) for 2 h at 16,000 rlam, 4"C in a Beckmann SW 27 rotor (Beckman Instruments, lnc,, Munich, FRG). Membrane fractions were harvested from the 0.8-1.2 M sucrose interface and pelleted by centrifugation for 30 rain at 40,000 rpm in a Beckmann Tl 50 rotor at 4'C. The pellet was resuspended in l0 ml Tris buffer containing 1% saponin and 10% glycerol. The saponininsoluble fraction was pelleted by centrifugation as described above. The pellet was resuspended in 2 ml 20 mM Tris buffer containing 1% deoxycholate, and the detergent-insoluble fraction was again pelleted. The deoxycholate-soluble components were fractionated according to their molecular weights on a Sephacryl S-400 (Pharmacia Inc.. Freiburg, FRG) column (60 ml). The filtrate (90 ml) was collected in 3-ml fractions. A sample of every fifth fraction was concentrated by precipitation with 70% ammonium sulfate, dialyzed against Tris buffer, and examined by SDS PAGE. The fractions were then pooled into three batches containing the high, medium, and low molecular weight proteins. Immunization with the 80-200-kD fraction resulted in monoclonal antibody N-CAMps0.
Monoclonal N-CAM;8o Antibody: FI hybrid rats were injected subcutaneously and intraperitoneally with 200 ~g protein each at days l, 15, 2!, and 40. The first two injections were made in complete, the following in incomplete Freund's adjuvant (Sigma Chemical Co., Munich, FRG). At day 47 the antibody titer was determined by indirect immunofluorescent staining of living cell cultures from early postnatal mouse cerebellum (see below). The rat was boosted on day 50 and 3 d later was killed for preparation of spleen cells. Fusion of spleen cells with the mouse myeloma cell line X63-Ag8653 was carried out as described previously (20) . Approximately 2,000 hybridoma supernatants were screened by the immunospot binding test (14) using saponininsoluble, deoxycholate-solubilized material of neonatal mouse brains prepared as described in the previous paragraph. Positive supernatants were then examined by indirect immunofluorescence on sections of fresh frozen cerebella from 5-d-old mice and on cell cultures of 5-d-old mouse cerebellum maintained for several days in vitro. One of these hybridomas (clone 481) produced a monoclonal antibody that recognized N-CAM~80.
Antibodies: Monoclonal antibody H28.123 and the polyclonal antibody to N-CAM have been described (12) . Peroxidase-conjugated rabbit antirat and goat anti-rabbit immunoglobulin antibodies and fluorescein-conjugated rabbit anti-rat and sheep anti-rabbit immunoglobulin antibodies were obtained commercially from Cappel Laboratories (Dynatech. Denkendorf, FRG). Monoclonal antibodies Ol and 04 reacting with oligodendrocyte cell surfaces, polyclonal antibodies to glial fibrillary acidic protein and vimentin reacting with astrocytes, and LI antibodies and tetanus toxin reacting with neurons have been described previously (9, 28, 35, 37, 39, 41) . Monoclonal antibody N-CAM~so, which is an lgG, was directly coupled to fluorescein according to Johnson et al. (17) . In brief, serum-free hybridoma supernatant containing monoclonal N-CAM;8o antibody was concentrated by ammonium sulfate precipitation and dialyzed extensively against 50 mM Na2CO3 buffer, pH 9.5, mixed with 40 ~g fluorescein isothiocyanate (Sigma Chemical Co.) at a concentration of I mg/ml protein (1.5 mg total) and shaken gently for 3.5 h at 4"C. The fluorescein-coupled antibodies were purified by gel filtration using a Sephadex G25 (Pharmacia Inc.) column (20 ml).
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THE JOURNAL OF CELL BIOLOGY " VOLUME 101, 1985 Cell Cultures: Primary cultures of cerebella from 13-d-old mouse embryos and neonatal and 7-d-old mice were prepared and maintained as monolayers on poly-L-lysine-coated coverslips as described (37, 38) . The mouse neuroblastoma Cl300 N2A clone was cultured in tissue culture flasks using Dulbecco's modified Eagle's medium (high glucose) containing 10% fetal calf serum (Seromed, Munich, FRG) and antibiotics as described (28) . For treatment with dimethylsulfoxide (DMSO) N2A cells were seeded in Dulbecco's modified Eagle's medium containing 0.2% fetal calf serum and 2% DMSO. The culture medium was changed every 2 d. For indirect immunofluorescence cells were seeded on glass coverslips coated with poly-L-lysine and maintained for several days in culture.
Immunocytological Procedures: Sections, 10-um thick, were prepared in a cryostat (Jung, Nussloch, FRG), mounted on poly-L-lysine-coated glass coverslips, and air dried for l h at room temperature. Indirect immunofluorescent staining of sections was performed as decribed by Schnitzer and Schachner (37) . For indirect immunofluorescence staining of monolayer cultures, cells were maintained in vitro for 3-4 d and examined by single-and double-immunolabeling procedures also as described by Schnitzer and Schachner (37) . For permeabilization of cells coverslips were dipped for 30 s in 96% ethanol at -20"C, followed by a 15-min wash with phosphate-buffered saline, pH 7.3 (PBS) and subsequent incubation for 15 min at room temperature with blocking buffer (PBS containing 0. 1% bovine serum albumin [BSA] and 1% horse serum) to saturate unspecific binding sites. For double immunolabeling procedures involving cell surface-and intracellularly localized antigens, indirect immunofluorescence was carried out first for the cell surface antigen. Then, cells were permeabilized by treatment with ethanol (see above) and processed for indirect immunofluorescence as described. Western Blot Analysis of DMSO-treated N2A Cells: N2A cells were maintained in culture in low serum and DMSO (see cell cultures) for various time periods (up to 8 d), harvested at room temperature by gently pipetting in PBS containing 1 mM EDTA, washed once, and sonicated in 10 mM Tris HCI, pH 8 containing 5 mM MgCI2, 0.2 mM leupeptin, 5 mM iodoacetamide, 0.1 mM phenylmethylsulfonyl fluoride, 20 ~g/ml aprotinin, and 0.1 mM 2-deoxy-2, 3-dehydro-N-acetyl-neuraminic acid. After addition of Nonidet P-40 (final concentration 1%), the sonicate was left for 15 rain on ice and centrifuged for 10 min at 8,000 g and 4"C. Supernatants were adjusted to 10 mg/ml protein (23) , and supematant aliquots were mixed with an equal volume of sample buffer (19) containing 5.6% SDS, 10% beta-mercaptoethanol and boiled for 3 rain. SDS PAGE (6.7% slab gels) was performed as described by Laemmli (19) . Electrophoretic transfer of proteins from gels to nitrocellulose filters was carried out according to Towbin et al. (43) . Polyclonal antibodies to N-CAM were incubated with the nitrocellulose filters and revealed as described by Burnett (2).
Western Blot Analysis of tmmunopurified N-CAM and Membrane Fractions of Adult Mouse Brain: N-CAM was purified
from adult mouse brain by immunoaffinity chromatography using monoclonal antibody H28.123 as described previously (29) . Crude membrane fractions from embryonic, neonatal, and adult mice were prepared as described by Rathjen and Schachner (28) . SDS PAGE was performed on 4-15% acrylamide slab gels. Proteins fractionated by SDS PAGE were transferred to nitrocellulose filters and processed for Western blot analysis with horseradish peroxidaseconjugated antibodies as described previously (10) . Protein determinations were carried out according to Lowry et al. (23) .
RESULTS
Monoclonal N-CAM~so antibody selectively reacts with the 180-kD component of the neural cell adhesion molecule N-CAM immunopurified from adult mouse brain, but not with the other two components of 140 and 120 kD (Fig. 1, A and  B) . Also in crude membrane preparations of adult mouse and c) and astrocytes (arrows in d, e, and f) are stained by both brain (Fig. 1C) , in which all three components of N-CAM are recognized by polyclonal antibodies (Fig. 1D) , only the 180-kD chain and no additional components are detected by the monoclonai antibody (Fig. 1 E) . The antibody also reacts in crude membrane preparations from neonatal ( Fig. 1 G) and 14-d-old fetal (Fig. 1 I) mouse brains with the embryonic polysialylated form ranging in apparent molecular weight from 180 to 250 kD.
To evaluate whether N-CAM18o is expressed in the same cell types or cells as N-CAM, double immunolabeling experiments were carried out on primary cultures of cerebellum from 13-d-old embryos (after 4 and 8 d in vitro), and neonatal (4 d in vitro) and 7-d-old (4 d in vitro) mice. A complete overlap in staining of antibody N-CAM~8o with monoclonal N-CAM antibody H28.123 or polyclonal N-CAM antibody is seen at all ages studied (see Fig. 2 for neonatal mouse cerebellum). As has been observed previously for monoclonal and polyclonal N-CAM antibodies, not only neurons but also astrocytes (17a, 21, 25, 40) and oligodendrocytes (17a) are stained by monoclonal N-CAM~so antibody (see Fig. 2 , b and e for morphologically identified glial cells). N-CAM~so is identified on glia by double immunofluorescence with established markers: vimentin and glial fibrillary acidic protein for astrocytes, and 04 and O 1 antigens for oligodendrocytes (not shown) (9, 39, 41) . The epitope recognized by monoclonal NCAMt8o antibody is apparently localized intracellularly, since cultured cells have to be permeabilized by treatment with aldehyde and ethanol to obtain immunolabeling. Treatment of live cultured cells with trypsin (1 mg/ml for 20 min at 37°C) does not reduce immunofluorescence staining with N-CAM~SO antibodies, but decreases staining intensity for antibody H28.123 (see also reference 12).
To determine whether during development N-CAM~so is expressed independently of the other two components of N-CAM, three regions of the central nervous system--telencephalon, retina, and cerebellummwere investigated by indirect immunofluorescence using histological sections. Monoclonal antibody H28.123, which recognizes a surface localized epitope on all three components of N-CAM, and polydonal N-CAM antibodies were used for comparison (29) . In all three regions of the developing mouse central nervous system N-CAM,so is found to be restricted to the more differentiated neural cells, whereas total N-CAM is also detected in the germinative zones containing proliferating neural precursor cells and in their direct postmitotic descendants.
In the developing 3-d-old retina, N-CAMISO is expressed in the ganglion cell layer, inner plexiform layer, and inner part of the nuclear layer (Fig. 3a) . The outer part of the nuclear layer containing proliferating neuronal precursor cells is only weakly stained by N-CAM~SO antibody (Fig. 3a) . In contrast, antibody H28.123 reacts with all layers and stains the whole width of the nuclear layer uniformly (Fig. 3b) . Similarly, in the telencephalic anlage of 14-d-old embryos, N-CAM,SO is expressed in the marginal zone and developing cortical plate, but not in the intermediate zone and ventricular layer (Fig.  4, a and c) which contain the less differentiated migrating neurons and proliferating neural precursors. Antibody H28.123 reacts with all layers (Fig. 4c) . Finally, in the cerebellum of 14-d-old mouse embryos, N-CAMjso antibodies stain only the intermediate zone, while antibodies to total N-CAM react additionally with the two germinative zones of the cerebellar anlage, the ventricular zone, and the primordial external granular layer (not shown). At postnatal day 7 N-CAMLSO is not detectable in the outer parts of the external granular layer and is only weakly apparent in the inner part of this layer (Fig. 5, a and e) , with a characteristic speckled appearance of the immunofluorescence (Fig. 5 e) . In contrast, antibodies to total N-CAM stain the full width of the external granular layer (Fig. 5, c and g ). Both antibodies react with prospective white matter, Purkinje cells, and nascent molecular layer. In the adult cerebellum both antibodies show a similar staining pattern with label in all layers, but most prominently in the molecular layer of the cerebellum (21). However, the overall staining intensity is markedly reduced with N-CAM~8o antibodies.
The apparent absence of N-CAM~8o expression in the less differentiated neural cell populations suggested that NCAM~so is involved in more differentiated functions, such as neurite outgrowth and formation of particular cell contacts. We therefore investigated the expression of N-CAM~so in the clonal cell line N2A of the mouse C1300 neuroblastoma in culture. N-CAM~8o is concentrated at contact points between most, but not all cells. The expression of N-CAMIso is much reduced at the surface membrane devoid of contact points (Fig. 6 b) . This phenomenon is not apparent with the H28.123 antibody (Fig. 6 d) . The more uniform distribution seen with the H28.123 antibody is observed whether cells are labeled live or after fixation with ethanol, thus excluding the possibility that ethanol treatment induces a redistribution of N-CAM. The independent regulation of the expression of the individual N-CAM components seen by immunofluorescence is demonstrated immunochemically in N2A cells induced to differentiate morphologically in the presence of DMSO and low serum concentrations (1, 18) . Over a time course of several days after seeding the cells in DMSO and low serum, the N-CAM140 band gradually disappears, whereas the concentration of N-CAMt8o changes only slightly (Fig. 7) . N2A FIGURE 6 Immunofluorescence localization of N-CAM180 in monolayer cultures of the mouse C1300 neuroblastoma clone N2A. Cells were permeabilized with ethanol and stained with N-CAM180 antibody (b) and antibody H28.123 (d and f). In f, cultures were maintained in low serum and DMSO for 6 d to induce morphological differentiation. N-CAM18o is predominantly localized at contact sites between neighboring ceils (b), whereas antibody H28.123 shows a more uniform staining over the surface membrane (d). Note the striking restriction of N-CAM immunostaining with antibody H28.123 at contact sites between cells grown in low serum and DMSO (f). a, c, and e are the corresponding phase contrast micrographs to fluorescence images b, d, and f, respectively. Bars, 50 #m. cells express very little, if any, of the 120-kD component. This shift is also seen when neuraminidase-treated material is analyzed, showing that the 180-kD band is not a hypersialylated form of N-CAMj,o in this case. When N-CAM is visualized on DMSO-treated N2A cells by immunofluorescence staining with the H28.123 antibody, a striking concentration of N-CAM at the sites of cell to cell contact is also seen (Fig.  6 , e and J). In this instance the H28.123 antibody localizes mainly the 180-kD component, the predominant form of N- CAM expressed in these differentiated cells.
N-CAM~8o antibody reacts less strongly than does the H28.123 antibody with shorter, filopodia-like processes protruding from the cell bodies of N2A cells (Fig. 8, b and J) . However, once neurite-like processes have extended over longer distances from the cell bodies, N-CAMI8o antibody also stains these (Fig. 8, d and h).
DISCUSSION
We have shown that the 180-kD component of N-CAM (N-CAM~8o) is not detectable by immunohistology in neural precursor cells in mouse cerebellum, retina, and telencephalon and appears developmentally later than either N-CAM14o or N-CAM~2o. In particular, the dividing precursors of granule cells in the external granular layer of the developing cerebellum do not express N-CAM~8o, whereas their progeny, the postmitotic granule cells of the inner zone of the external granular layer, is clearly labeled by anti-N-CAMm80. This indicates that the expression of the individual N-CAM components may be independently regulated at distinct stages of the neuronal cell lineage. In line with these findings we could show by Western blot analysis that the expression of the 180-and 140-kD components is regulated according to the stage of differentiation in the N2A clone of mouse C 1300 neuroblastoma. Compared with the undifferentiated cells, which express predominantly the 140-kD component, DMSO-induced differentiation leads to almost exclusive expression of N-CAMIgo.
Our study cannot rigorously exclude the possibility that during nervous tissue development the antigenic site of antibody N-CAMIgo is inaccessible or modified in such a way that it cannot be recognized by the antibody in histological sections. Direct assessment of this possibility is, however, difficult since quantitative Western blot analysis of the individual components in isolated membrane fractions at early developmental stages is hampered by small quantities and consid- A role of N-CAM~80 in neurite extension is suggested by the observation that short, filopodia-like processes of neuroblastoma cells do not carry detectable levels of N-CAM~8o, while longer, neurite-like processes do. Also, N-CAMts0 may be involved in cell contact mechanisms as suggested by the observation that at the sites of close cell apposition N-CAM~8o is more concentrated than total N-CAM, particularly in DMSO-treated morphologically differentiated neuroblastoma cells. Interestingly, the membrane-cytoskeleton linker protein fodrin is also more concentrated at contact points (unpublished observations). It is noteworthy in this respect that the monoclonal N-CAM18o antibody resulted from an immunization with a subcellular fraction likely to be enriched for cytoskeleton-associated proteins (26) . It is therefore conceivable that a cytoskeleton-mediated reduction in lateral mobility within the plasma membrane is a particular feature of NCAM18o. This stabilization within the membrane may be mediated by the longer cytoplasmic domain of N-CAM18o. However, this conjecture remains to be proven.
